Physician profile
David L Stuart
NPI 1518171628
$12,675.00
in general payments reported to CMS, 2019-2025
16 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $18.45 · 2021: $322 · 2022: $9,171 · 2023: $152 · 2024: $2,657 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,498 · Food and Beverage: $1,408 · Education: $13.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,498.18 |
| Food and Beverage | $1,408.44 |
| Education | $13.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,915.09 | 2021-2024 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $634.24 | 2022 | |
| Ethicon US, LLC | $333.76 | 2019-2024 | Vistaseal, Prolene, Stratafix |
| Organogenesis INC. | $242.50 | 2019-2022 | |
| Stryker Corporation | $148.85 | 2019 | |
| Smith+Nephew, INC. | $135.97 | 2023-2025 | Collagenase Santyl |
| Abbvie INC. | $55.16 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $36.58 | 2023 | Andexxa |
| Merck Sharp & Dohme LLC | $35.34 | 2024 | Verquvo |
| Abbott Laboratories | $24.60 | 2025 | Jot Dx |
| Kerecis Limited | $24.41 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Lilly USA, LLC | $21.43 | 2023 | Emgality, Jardiance |
| Medtronic, INC. | $21.15 | 2024 | |
| La Jolla Pharmaceutical Company | $19.64 | 2025 | Giapreza |
| Novo Nordisk INC | $17.68 | 2025 | Wegovy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $8.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.